Fog Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane in 2015 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Parabilis Medicines Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Parabilis Medicines Inc. market cap is $99.26M.
What is the 52-week high for Parabilis Medicines Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Parabilis Medicines Inc. 52 week high is $34.47 as of June 12, 2026.
What is the 52-week low for Parabilis Medicines Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Parabilis Medicines Inc. 52 week low is $20.00 as of June 12, 2026.
What is Parabilis Medicines Inc. stock price today?
Parabilis Medicines Inc. stock price today is $30.31.
What was Parabilis Medicines Inc. stock price yesterday?
Parabilis Medicines Inc. stock price yesterday was $31.60.
What is the Price-to-Book ratio of Parabilis Medicines Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Parabilis Medicines Inc. P/B ratio is -6.2789.
What is the 50-day moving average of Parabilis Medicines Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Parabilis Medicines Inc. 50-day moving average is $27.30.